Pentwater Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,970,000
Closed -$83M 149
2023
Q2
$83M Buy
1,970,000
+1,880,795
+2,108% +$76M 0.57% 24
2023
Q1
$3.18M Buy
+89,205
New +$3.24M 0.03% 97

Other funds holding SYNH

Pentwater Capital Management's SYNH Position: Q3 2023 in Review

Pentwater Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,970,000 shares — an estimated $83M sold.

Pentwater Capital Management first reported a position in SYNH in Q1 2023 and held it in 2 quarters. The position peaked at $83M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Pentwater Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Pentwater Capital Management sold 1,970,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $83M.
  • Pentwater Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2023 and held it in 2 quarters.
  • Pentwater Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $83M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Pentwater Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.